This summary was created by AI, based on 1 opinions in the last 12 months.
IDEXX Laboratories is a company that manufactures diagnostic equipment for veterinarians. The stock initially sold off due to concerns about the impact of Covid on pet-related stocks, but has seen a recovery since then. The company reported a beat in early August, which gave it a short-term boost, but shares have been trading relatively flat since that report. Overall, it seems to be recovering from the Covid-related hit, but investors are taking a wait-and-see approach.
IDEXX Laboratories is a American stock, trading under the symbol IDXX-Q on the NASDAQ (IDXX). It is usually referred to as NASDAQ:IDXX or IDXX-Q
In the last year, 1 stock analyst published opinions about IDXX-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for IDEXX Laboratories.
IDEXX Laboratories was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for IDEXX Laboratories.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered IDEXX Laboratories In the last year. It is a trending stock that is worth watching.
On 2024-03-28, IDEXX Laboratories (IDXX-Q) stock closed at a price of $539.78.
Makes diagnostic equipment for veterinarians. It has sold off hard, because pet plays are seen as Covid stocks, but has been recovering (reported a beat in early August), but shares have been cold since that report.